Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Granule Wakamoto
- Development stage
- Unknown
- Lead developer
- Wakamoto
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Administration
- Oral
01
Overview
Granule Wakamoto is an over-the-counter gastrointestinal remedy formulated as a granule. It is approved in Japan as a designated quasi-drug. The formulation features a triple-action combination of three natural active ingredients: Aspergillus oryzae NK culture powder, lactic acid bacteria culture powder (specifically Streptococcus faecalis), and dry yeast (brewer's yeast), supplemented with B vitamins (thiamine nitrate, riboflavin, and nicotinamide). Aspergillus oryzae NK culture powder produces digestive enzymes (such as amylase, protease, and lipase) to assist digestion and relieve stomach heaviness and indigestion. The lactic acid bacteria culture powder regulates the intestinal flora, suppressing harmful bacteria and alleviating abdominal bloating, constipation, and loose stools. Dry yeast provides essential nutrients, including amino acids, minerals, and B vitamins, to support nutritional replenishment and combat physical fatigue. Developed and manufactured by Wakamoto, Granule Wakamoto is designed for individuals of all ages experiencing gastrointestinal discomfort, overeating, or fatigue.
- Brand names
- Granulated WakamotoGranule WakamotoGranules WakamotoRuoben Granule
- Other names
- Wakamoto Gastrointestinal GranulesWakamoto Granules顆粒わかもと
Beyond the preview
Go deeper on Granule Wakamoto.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Granule Wakamoto.